Posted on 28 April 2011.
It has been reported that generic pharmaceuticals manufacturer, Actavis was able to deliver 10 million Levothyroxine tablets to Japan in order to help supply the shortage of Levothyroxine after the devastating earthquake on 11th March – these tablets were produced and delivered within only twenty days after requested for the treatment of thyroid problems. Read the full story
Posted in Business, General, Iceland, International, Society, United KingdomComments (1)
Posted on 03 November 2008.
New analytical and research and development laboratories were opened in a United States division of the international generic pharmaceutical company Actavis.
The labs help expand the research and development efforts for controlled release drugs and other technically difficult generic pharmaceutical products. Read the full story
Posted in Business, Iceland, MBL, Technology, United StatesComments (0)
Posted on 16 October 2008.
The operations of generic pharmaceutical company Actavis will not be affected by the financial crisis in Iceland, the company reports.
Actavis, which has its headquarters in Reykjavik, is a leading generic pharmaceuticals manufacturer with operations in 40 countries and 11,000 employees.
Posted in Business, Iceland, International, MBLComments (0)
Posted on 06 October 2008.
Actavis, a generic drugs manufacturer based in Iceland, has received approval from the US Food & Drug Administration to market the generic breast cancer drug, Epirubicin Hydrochloride Injection, in the United States.
The drug will be Actavis’ second oncology drug introduced to the US this year.
Epirubicin Hydrochloride Injection, the generic to Pfizer’s Ellence, is prescribed to patients with evidence of axillary node tumours following resection of primary breast cancer.
Posted in Iceland, MBL, Technology, United StatesComments (0)
Posted on 06 July 2008.
Iceland-based generic drugs manufacturer Actavis announced this week it has sold a product portfolio of seven established brands on the Polish market to Glenmark Pharmaceuticals, an Indian company hoping to increase its presence in eastern and central Europe.
The sale took effect on 1st July, but neither company revealed the amount of money paid. The portfolio of seven products includes the antidepressant Cital and Lamotrix, which is used to treat epilepsy.
Actavis undertook the deal in collaboration with Biovena, its Polish subsidiary, in a bid to streamline the generic drug company‘s activities in Poland.
Actavis has acquired more than 20 companies in recent years, which it is now integrating into its existing product portfolio.
Actavis is one of the leading generic drugs manufacturers in the world, with operations in 40 countries and 11,000 employees.
More information on Actavis can be found at www.actavis.com.
Posted in Business, International, MBL, TechnologyComments (0)
Iceland’s Kaupthing bank repaid billions
Utøya witness: Breivik whooped with joy
H&M burned by tanned model criticism
Iceland president: beating drugs is simple
Leftists ‘arson terrorists’ released from custody in Denmark
Successful ending to safety landing at Keflavík Airport in Iceland
Famous Finland husband murder case to be reopened
Dermatologist Dr. Ron Moy gives BIOEFFECT EGF SERUM seal of approval
Teenager arrested for Copenhagen park attack
Mangs’ mother noticed racism
